463 related articles for article (PubMed ID: 17056829)
1. Dose of aspirin in the treatment and prevention of cardiovascular disease: current and future directions.
Hennekens CH; Sechenova O; Hollar D; Serebruany VL
J Cardiovasc Pharmacol Ther; 2006 Sep; 11(3):170-6. PubMed ID: 17056829
[TBL] [Abstract][Full Text] [Related]
2. Update on aspirin in the treatment and prevention of cardiovascular disease.
Hennekens CH
Am J Manag Care; 2002 Dec; 8(22 Suppl):S691-700. PubMed ID: 12512736
[TBL] [Abstract][Full Text] [Related]
3. A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women.
Ridker PM; Cook NR; Lee IM; Gordon D; Gaziano JM; Manson JE; Hennekens CH; Buring JE
N Engl J Med; 2005 Mar; 352(13):1293-304. PubMed ID: 15753114
[TBL] [Abstract][Full Text] [Related]
4. The need for wider and appropriate utilization of aspirin and statins in the treatment and prevention of cardiovascular disease.
Hennekens CH; Schneider WR
Expert Rev Cardiovasc Ther; 2008 Jan; 6(1):95-107. PubMed ID: 18095910
[TBL] [Abstract][Full Text] [Related]
5. Low-dose aspirin for primary prevention of cardiovascular disease.
Bredie SJ; Wollersheim H; Verheugt FW; Thien T
Semin Vasc Med; 2003 May; 3(2):177-84. PubMed ID: 15199480
[TBL] [Abstract][Full Text] [Related]
6. Additive benefits of pravastatin and aspirin to decrease risks of cardiovascular disease: randomized and observational comparisons of secondary prevention trials and their meta-analyses.
Hennekens CH; Sacks FM; Tonkin A; Jukema JW; Byington RP; Pitt B; Berry DA; Berry SM; Ford NF; Walker AJ; Natarajan K; Sheng-Lin C; Fiedorek FT; Belder R
Arch Intern Med; 2004 Jan; 164(1):40-4. PubMed ID: 14718320
[TBL] [Abstract][Full Text] [Related]
7. The C50T polymorphism of the cyclooxygenase-1 gene and the risk of thrombotic events during low-dose therapy with acetyl salicylic acid.
Clappers N; van Oijen MG; Sundaresan S; Brouwer MA; Te Morsche RH; Keuper W; Peters WH; Drenth JP; Verheugt FW
Thromb Haemost; 2008 Jul; 100(1):70-5. PubMed ID: 18612540
[TBL] [Abstract][Full Text] [Related]
8. Aspirin and primary cardiovascular prevention. Uncertain balance between benefits and risks.
Prescrire Int; 2010 Nov; 19(110):258-61. PubMed ID: 21284360
[TBL] [Abstract][Full Text] [Related]
9. Low-dose aspirin in patients with stable cardiovascular disease: a meta-analysis.
Berger JS; Brown DL; Becker RC
Am J Med; 2008 Jan; 121(1):43-9. PubMed ID: 18187072
[TBL] [Abstract][Full Text] [Related]
10. [Aspirin in cardiovascular prevention: does the approach differ by gender?].
Temizhan A
Anadolu Kardiyol Derg; 2007 Dec; 7 Suppl 2():2-4. PubMed ID: 18160359
[TBL] [Abstract][Full Text] [Related]
11. Aspirin in the primary prevention of cardiovascular disease.
Hennekens CH; Buring JE
Cardiol Clin; 1994 Aug; 12(3):443-50. PubMed ID: 7805078
[TBL] [Abstract][Full Text] [Related]
12. [Primary prevention of cardiovascular diseases with acetylsalicylic acid].
Waltering A; Hemkens L; Florack C
Dtsch Med Wochenschr; 2005 Dec; 130(49):2847-52. PubMed ID: 16317615
[TBL] [Abstract][Full Text] [Related]
13. [Secondary prevention after acute myocardial infarction: aspirin, warfarin or both?].
Reikvam A; Madsen S; Landmark K
Tidsskr Nor Laegeforen; 2003 Jun; 123(13-14):1838-40. PubMed ID: 12830258
[TBL] [Abstract][Full Text] [Related]
14. An update on aspirin in the primary prevention of cardiovascular disease.
Eidelman RS; Hebert PR; Weisman SM; Hennekens CH
Arch Intern Med; 2003 Sep; 163(17):2006-10. PubMed ID: 14504112
[TBL] [Abstract][Full Text] [Related]
15. Aspirin in cardiovascular disorders. What is the optimum dose?
Kong DF
Am J Cardiovasc Drugs; 2004; 4(3):151-8. PubMed ID: 15134467
[TBL] [Abstract][Full Text] [Related]
16. Aspirin as an antithrombotic drug: from the aggregometer to clinical trials.
de Gaetano G
Verh K Acad Geneeskd Belg; 1990; 52(6):459-71; discussion 471-3. PubMed ID: 2150736
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of aspirin in the long-term management of atherothrombosis.
Patrono C
Haematologica; 2002 Jan; 87(1):6-8. PubMed ID: 11801459
[No Abstract] [Full Text] [Related]
18. Aspirin: promise and resistance in the new millennium.
Patrono C; Rocca B
Arterioscler Thromb Vasc Biol; 2008 Mar; 28(3):s25-32. PubMed ID: 18174450
[TBL] [Abstract][Full Text] [Related]
19. Who needs antiplatelet therapy?
Moher M; Lancaster T
Br J Gen Pract; 1996 Jun; 46(407):367-70. PubMed ID: 8983259
[TBL] [Abstract][Full Text] [Related]
20. Low-dose aspirin in primary prevention: cardioprotection, chemoprevention, both, or neither?
Patrono C
Eur Heart J; 2013 Nov; 34(44):3403-11. PubMed ID: 23771843
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
